Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03016377
Title Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center

B-cell acute lymphoblastic leukemia


Anti-CD19 CAR T cells

Cyclophosphamide + Fludarabine

Age Groups: child | adult | senior
Covered Countries USA

No variant requirements are available.